tetano
Editor, Senior Moderator
Int J Antimicrob Agents
. 2020 Jun 13;106052.
doi: 10.1016/j.ijantimicag.2020.106052. Online ahead of print.
Five Severe COVID-19 Pneumonia Patients Treated With Triple Combination Therapy With lopinavir/ritonavir, Hydroxychloroquine, and Interferon β-1b
Sun In Hong[SUP] 1 [/SUP], Byung-Han Ryu[SUP] 1 [/SUP], Yong Pil Chong[SUP] 2 [/SUP], Seungjun Lee[SUP] 3 [/SUP], Sunjoo Kim[SUP] 3 [/SUP], Ho Cheol Kim[SUP] 4 [/SUP], Kyung-Wook Hong[SUP] 5 [/SUP], In-Gyu Bae[SUP] 6 [/SUP], Oh-Hyun Cho[SUP] 7 [/SUP]
Affiliations
Abstract
No abstract availableKeywords: COVID-19; Coronavirus; Hydroxychloroquine; Interferon; Lopinavir/ritonavir; SARS-CoV-2.
. 2020 Jun 13;106052.
doi: 10.1016/j.ijantimicag.2020.106052. Online ahead of print.
Five Severe COVID-19 Pneumonia Patients Treated With Triple Combination Therapy With lopinavir/ritonavir, Hydroxychloroquine, and Interferon β-1b
Sun In Hong[SUP] 1 [/SUP], Byung-Han Ryu[SUP] 1 [/SUP], Yong Pil Chong[SUP] 2 [/SUP], Seungjun Lee[SUP] 3 [/SUP], Sunjoo Kim[SUP] 3 [/SUP], Ho Cheol Kim[SUP] 4 [/SUP], Kyung-Wook Hong[SUP] 5 [/SUP], In-Gyu Bae[SUP] 6 [/SUP], Oh-Hyun Cho[SUP] 7 [/SUP]
Affiliations
- PMID: 32544570
- DOI: 10.1016/j.ijantimicag.2020.106052
Abstract
No abstract availableKeywords: COVID-19; Coronavirus; Hydroxychloroquine; Interferon; Lopinavir/ritonavir; SARS-CoV-2.